All Type of News
Will Pradaxa catch up with launching it as reversal agent?
Novel oral anticoagulants(NOAC) have started to be ranked in a year after they were applied for the National Health Insurance as the primary treatment for stroke prevention in treating stroke and embolism for atrial f...
Is distribution companies’ duty to supply drugs switched to quasi?
Pharmaceutical companies were known to feel pressured on directly providing large supermarkets products, which are switched from regular drugs to quasi drugs in 2011.
According to the distribution industry, pharmaceu...
Demo project on Western-Korean Joint Medical Service starts from July 15
The ‘Demonstration Project to Invigorate the Western-Korean Joint Medical Service,’ which applies the health insurance benefit on using both doctors and Korean medicine doctors, will be actively implemented at 13 hosp...
When domestic companies will win patent suits over ‘Revlimid’?
Domestic pharmaceutical companies have filed patent suits to preoccupy the market of the multiple myeloma therapy whose substance patent will be expired next year, ‘Revlimid,’ but they continued failure.
Celgene’s ...
Is the government’s new improvement measure gain or loss?
Will the government’s improvement measure for preferential prices on global innovative drug be gain or loss?
It was analyzed it needs to be discussed if the improvement measure will be a suitable system for the indu...
Inflow of foreign investments into distribution industry, will it be ok?
As foreign investments are flowing into the pharmaceutical distribution industry, it was analyzed competitiveness of domestic pharmaceutical distribution companies has actually been tested.
Speaking of investments, ...
Pharmaceutical industry shows embarrassment over prosecution’s inspections
The prosecution’s rebate inspections over pharmaceutical companies and doctors have taken unexpected directions.
This is because the prosecution pushed forward with search and seizure on a well-known pharmaceutical c...
LG Life Sciences conclude joint sales agreement of Micera with Roche Korea
On the 11th, LG Life Sciences(CEO Il-jae Jung) and Roche Korea(CEO Matt Sause) announced conclusion of the joint sales agreement of Mircera, a anemia treatment for chronic kidney disease patients. Micera is a product ...
MOHW approves somatic cell cloning embryo study in 7 years
The Ministry of Health and Welfare(MOHW) attracted attention as approving a somatic cell cloning embryo research in 7 years since the year of 2009.
The MOHW conditionally approved the somatic cell cloning embryo rese...
“Leaked patient information” vs “collection of information for statistic process”
The prosecution conducted the examination of witnesses on IMS Health, Ginus and the Korea Pharmaceutical Information Center that were accused of violating the Personal Information Protection Law in regards of leaking ...
